Finished Dosage Form (FDF) export of Lubabegron fumarate obtained from Indian Custom Trade Statistics

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Lubabegron fumarate [usan], Lubabegron hemifumarate, 391926-19-5, Ly591281, Ly-591281, 35441865uu
Molecular Formula
C62H62N6O10S2
Molecular Weight
1115.3  g/mol
InChI Key
MEEKSPBNXICJNQ-CXUXXADZSA-N
FDA UNII
35441865UU

Lubabegron fumarate
1 2D Structure

Lubabegron fumarate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(E)-but-2-enedioic acid;2-[4-[2-[[(2S)-2-hydroxy-3-(2-thiophen-2-ylphenoxy)propyl]amino]-2-methylpropyl]phenoxy]pyridine-3-carbonitrile
2.1.2 InChI
InChI=1S/2C29H29N3O3S.C4H4O4/c2*1-29(2,17-21-11-13-24(14-12-21)35-28-22(18-30)7-5-15-31-28)32-19-23(33)20-34-26-9-4-3-8-25(26)27-10-6-16-36-27;5-3(6)1-2-4(7)8/h2*3-16,23,32-33H,17,19-20H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*23-;/m00./s1
2.1.3 InChI Key
MEEKSPBNXICJNQ-CXUXXADZSA-N
2.1.4 Canonical SMILES
CC(C)(CC1=CC=C(C=C1)OC2=C(C=CC=N2)C#N)NCC(COC3=CC=CC=C3C4=CC=CS4)O.CC(C)(CC1=CC=C(C=C1)OC2=C(C=CC=N2)C#N)NCC(COC3=CC=CC=C3C4=CC=CS4)O.C(=CC(=O)O)C(=O)O
2.1.5 Isomeric SMILES
CC(C)(CC1=CC=C(C=C1)OC2=C(C=CC=N2)C#N)NC[C@@H](COC3=CC=CC=C3C4=CC=CS4)O.CC(C)(CC1=CC=C(C=C1)OC2=C(C=CC=N2)C#N)NC[C@@H](COC3=CC=CC=C3C4=CC=CS4)O.C(=C/C(=O)O)\C(=O)O
2.2 Other Identifiers
2.2.1 UNII
35441865UU
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Lubabegron Fumarate [usan]

2. Lubabegron Hemifumarate

3. 391926-19-5

4. Ly591281

5. Ly-591281

6. 35441865uu

7. Lubabegron Fumarate (usan)

8. Unii-35441865uu

9. Chembl2364616

10. D10645

11. Q27256417

12. 3-pyridinecarbonitrile, 2-(4-(2-(((2s)-2-hydroxy-3-(2-(2-thienyl)phenoxy)propyl)amino)-2-methylpropyl)phenoxy)-, (2e)-2-butenedioate (2:1) (salt)

13. Bis(2-(4-(2-(((2s)-2-hydroxy-3-(2-(thiophen-2-yl)phenoxy)propyl(amino)-2-methylpropyl)phenoxy(pyridine-3-carbonitrile) (2e)-but-2-enedioate

2.4 Create Date
2013-07-08
3 Chemical and Physical Properties
Molecular Weight 1115.3 g/mol
Molecular Formula C62H62N6O10S2
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count18
Rotatable Bond Count24
Exact Mass1114.39688454 g/mol
Monoisotopic Mass1114.39688454 g/mol
Topological Polar Surface Area306 Ų
Heavy Atom Count80
Formal Charge0
Complexity824
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty